IOL Chemicals announces Q2 & H1 FY26 investor presentation; CEP certification for Pantoprazole Process-III enables exports to Europe and CEP markets; UK subsidiary IOL Pharmaxis UK Limited is incorporated to bolster international operations.
AI Assistant
IOL Chemicals & Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.